Pathologic study of ocular lesions due to lewisite (B-chlorovinyldichloroarsine) changes with and without BAL (2,3-dimercaptopropanol) therapy.
D001152:Arsenicals; D004112:Dimercaprol; D005123:Eye / Q000473:pathology*; D005128:Eye Diseases; D005739:Gas Poisoning; D006801:Humans
D001152:Arsenicals; D004112:Dimercaprol; C035965:lewisite
EYES/diseases; EYES/pathology; GAS/poisoning